Clinical Trial

A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.
Protocol Amendment History 2 changes
critical Trial completed 2026-06-03
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-04-04
Trial Details
NCT Number NCT07481708
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 30 participants
Start Date 2026-03-23
Primary Completion 2026-05-18 (estimated)
Study Completion 2026-05-25 (estimated)
Updated on ClinicalTrials.gov 2026-06-02